Clinical Trials Browser

Recruiting × Interventional × Papillomavirus Infections × Clear all

NCT06498661 2026-03-18

SHIP-A-S01

Phase NA Recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07461818 2026-03-11

POC

Phase NA Recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07209189 2026-03-09

(NeoScorch HN)

Phase 2 Recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT07447245 2026-03-03

(HPV)

Phase NA Recruiting

Papillomavirus Infections

NCT07428330 2026-02-27

CASCADE3001A

Phase NA Recruiting

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT07225530 2026-02-25

(iSTAR)

Phase NA Recruiting

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT05334706 2026-02-23

RIFT-HPV

Phase 4 Recruiting

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

NCT07209917 2026-02-23

ASHA-Health II

Phase NA Recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms, Infections, Papillomavirus Infections

NCT07420556 2026-02-19

Effect of Different HPV Education Methods on Vaccination Intention in Young Women

Phase NA Recruiting

Health Education, Infections, Papillomavirus Infections

NCT07281430 2026-02-17

LMI-001-A-S04

Phase NA Recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07033091 2026-02-13

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

Phase NA Recruiting

20,000 enrolled

Oropharyngeal Neoplasms, Papillomavirus Infections

NCT07281599 2026-02-02

EQUIP

Phase NA Recruiting

Genital Diseases, Uterine Cervical Neoplasms, Sexually Transmitted Diseases, Sexually Transmitted Diseases, Viral, Papillomavirus Infections

NCT07320157 2026-01-22

HPV-Education

Phase NA Recruiting

Papillomavirus Infections

NCT05262010 2026-01-16

A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

Phase 3 Recruiting

13,500 enrolled

Papillomavirus Infections

NCT07336134 2026-01-13

PopSci CHW4CervixHealth

Phase NA Recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06458062 2026-01-12

Pocket Colposcopy Using CARE Algorithm

Phase NA Recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07275333 2025-12-18

Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine

Phase NA Recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Infections, Papillomavirus Infections

NCT06756269 2025-12-17

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

Phase 2 Recruiting

Condylomata Acuminata, Papillomavirus Infections

NCT06538480 2025-12-15

Zopa Retreatment and Vector Shedding in Adults With RRP

Phase 4 Recruiting

Recurrent respiratory papillomatosis, Papillomavirus Infections

NCT07281677 2025-12-15

Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years

Phase 4 Recruiting

Papillomavirus Infections

NCT06507917 2025-12-11

a-HPVVIH

Phase NA Recruiting

Papillomavirus Infections

NCT06380114 2025-10-24

Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination

Phase NA Recruiting

16,000 enrolled

Papillomavirus Infections

NCT05672927 2025-10-06

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

Phase 4 Recruiting

Papillomavirus Infections

NCT04098744 2025-10-02

ART-CIN_IIB

Phase 2 Recruiting

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT06397378 2025-09-25

HPV videos

Phase NA Recruiting

Papillomavirus Infections

NCT06075264 2025-08-14

ART-VIN IIB

Phase 2 Recruiting

Vulvar Diseases, Papillomavirus Infections

NCT05592626 2025-07-09

START-001

Phase 1/2 Recruiting

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Abdominal Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms by Site, Stomach Neoplasms, Urogenital Neoplasms, Vulvar Diseases, Vulvar Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Epstein-Barr Virus Infections, Papillomavirus Infections, Microsatellite Instability, Small Cell Lung Carcinoma

NCT05388773 2025-06-19

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Phase 2 Recruiting

Carcinoma, Squamous Cell, DNA Virus Infections, Head and Neck Neoplasms, Stomatognathic Diseases, Neoplasms, Glandular and Epithelial, Oropharyngeal Neoplasms, Otorhinolaryngologic Diseases, Otorhinolaryngologic Neoplasms, Papilloma, Pharyngeal Diseases, Pharyngeal Neoplasms, Tumor Virus Infections, Papillomavirus Infections

NCT06793410 2025-06-05

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Phase 2 Recruiting

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Papillomavirus Infections

NCT06052033 2025-05-13

Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection

Phase NA Recruiting

Squamous Intraepithelial Lesions, Papillomavirus Infections

NCT05266898 2025-04-18

AGO-Gard

Phase 4 Recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT06598475 2025-04-10

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

Phase NA Recruiting

Papillomavirus Infections

NCT04226313 2025-03-19

KOPRETINA

Phase NA Recruiting

15,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06784960 2025-03-07

Communication Strategies to Increase HPV Vaccination Intention

Phase NA Recruiting

Vaccination Hesitancy, Communication, Papillomavirus Infections

NCT06686043 2024-11-13

HPV-VIM

Phase 2 Recruiting

Uterine Cervical Neoplasms, Neoplasm Metastasis, Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Papillomavirus Infections

NCT06416150 2024-10-26

Reducing Urban Cervical Cancer Disparities

Phase NA Recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT05336240 2024-08-26

PCOM2

Phase NA Recruiting

Papillomavirus Infections

NCT06467942 2024-06-21

ELIMVLHPV

Phase NA Recruiting

Papillomavirus Infections

NCT06326294 2024-05-22

Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique

Phase NA Recruiting

HIV Infections, Papillomavirus Infections

NCT06371118 2024-05-14

HERSELF

Phase NA Recruiting

Uterine Cervical Neoplasms, Self-Examination, Papillomavirus Infections

NCT05860725 2024-05-09

Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy

Phase NA Recruiting

Vaccination Hesitancy, Papillomavirus Infections

NCT04895020 2024-04-17

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Phase 3 Recruiting

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT05027776 2024-04-17

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Phase 3 Recruiting

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Papillomavirus Infections

NCT05439083 2024-03-08

Immunogenicity of 9-valent HPV Vaccine

Phase 4 Recruiting

Papillomavirus Infections

NCT04910802 2021-09-16

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Phase 4 Recruiting

150,000 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections